| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/09/2010 | EP2192905A2 Method for the selective therapy of disease |
| 06/09/2010 | EP2192904A1 Methods for inhibiting tgf- |
| 06/09/2010 | EP2192902A1 Quinoline derivatives as p13 kinase inhibitors |
| 06/09/2010 | EP2192901A2 Chemicals, compositions, and methods for treatment and prevention of orthopoxvirus infections and associated diseases |
| 06/09/2010 | EP2192900A2 Substituted 5-vinylphenyl-1-phenyl-pyrazole cannabinoid modulators |
| 06/09/2010 | EP2192899A1 Transition metal complexes of corroles for preventing cardiovascular diseases or disorders |
| 06/09/2010 | EP2192898A1 Composition and method for increasing the anabolic state of muscle cells |
| 06/09/2010 | EP2192896A1 Carbonylamino derivatives useful for the treatment of certain inflammatory disorders |
| 06/09/2010 | EP2192894A2 Novel method for producing dry hydrodispersible pharmaceutical forms |
| 06/09/2010 | EP2192893A2 Antifungal composition |
| 06/09/2010 | EP2192889A2 Cosmetic methods and compositions for repairing human skin |
| 06/09/2010 | EP2192839A1 Synergistic pesticidal mixtures |
| 06/09/2010 | EP2192838A1 Heterocyclic inhibitors of necroptosis |
| 06/09/2010 | EP2192836A2 Fly control method |
| 06/09/2010 | EP2192835A1 Treatment of lung cancer |
| 06/09/2010 | EP2097374B1 5-alkyloxy-indolin-2-one derivatives, preparation thereof and application thereof in therapy as selective ligands of v2 vasopressin receptors |
| 06/09/2010 | EP2049508B1 N-hydroxy-3-(4-{3-phenyl-3-oxo-propenyl}-phenyl)-acrylamide derivatives and related compounds as histone deacetylase inhibitors for the treatment of cancer |
| 06/09/2010 | EP2029583B1 New benzothiazinone derivatives and their use as antibacterial agents |
| 06/09/2010 | EP1999126B1 Cyclic-alkylaminederivatives as inhibitors of the interaction between mdm2 and p53 |
| 06/09/2010 | EP1934224B1 Pyrazolopyrimidines as cyclin dependent kinase inhibitors for the treatment of cancer |
| 06/09/2010 | EP1919463B1 Use of hif 1alfa modulators for treatment of cancer |
| 06/09/2010 | EP1740584B9 Fused quinoline derivative and use thereof |
| 06/09/2010 | EP1740171B1 Indol-1-yl-acetic acid derivatives |
| 06/09/2010 | EP1730115B1 5-aminoalkylpyrazole derivatives as pesticidal agents |
| 06/09/2010 | EP1730110B1 Sulfur compounds as inhibitors of hepatitis c virus ns3 serine protease |
| 06/09/2010 | EP1720520B1 Particles comprising a core of calcium phosphate nanoparticles, a biomolecule and a bile acid, methods of manufacturing, therapeutic use thereof |
| 06/09/2010 | EP1711494B1 Aryl substituted heterocycles, method for production and use thereof as medicaments |
| 06/09/2010 | EP1497273B1 Hydroxamic acid derivatives |
| 06/09/2010 | EP1335907B1 Piperazinylpyrazine compounds as agonist or antagonist of serotonin 5ht-2 receptor |
| 06/09/2010 | EP1292308B1 Alpha,beta-unsaturated sulfones for treating proliferative disorders |
| 06/09/2010 | EP1270004B1 Use of gamma-tocotrienol as diuretic |
| 06/09/2010 | EP1228087B1 Antibody catalysis of enantio- and diastereo-selective aldol reactions |
| 06/09/2010 | EP1062226B1 High affinity nucleic acid ligands of the complement system c5 protein |
| 06/09/2010 | EP1011686B1 Modulation of human mast cell activation |
| 06/09/2010 | EP0951295B1 Compositions for use in inhibiting of alpha-v-beta3 mediated angiogenesis |
| 06/09/2010 | EP0914090B1 Antioxidant and/or antielastase dermatological composition based on lupine oil |
| 06/09/2010 | CN1994342B Externally applied anti-inflammation anti-allergy medicament composed of triamcinolone acetonide and cnidium fruit having few side effects |
| 06/09/2010 | CN1994289B Application of dibenzocyclootadiene lignans in preparation of tyrosine-inhibiting medicine |
| 06/09/2010 | CN1989132B Novel glucitol derivative, prodrug thereof and salt thereof, and therapeutic agent containing the same for diabetes |
| 06/09/2010 | CN1982324B Oncogene, recombinant protein derived therefrom, and uses thereof |
| 06/09/2010 | CN1956984B 1,3,4-oxadiazol-2-ones as PPAR-delta modulators |
| 06/09/2010 | CN1956711B Peroxisome proliferator-activated receptor (PPAR) activator and drugs, supplements, functional foods and food additives using the same |
| 06/09/2010 | CN1953985B Prodrugs of piperazine and substituted piperidine antiviral agents |
| 06/09/2010 | CN1950383B Phosphonates, monophosphonamidates, bisphosphonamidates for the treatment of viral diseases |
| 06/09/2010 | CN1946383B Multi-phase contraceptive preparation based on a natural estrogen |
| 06/09/2010 | CN1943625B Oral sterilizing liquid |
| 06/09/2010 | CN1939919B Low-toxic and broad-spectrum phthalocyanine bactericide, its production and use |
| 06/09/2010 | CN1938032B Sustained-release oral molsidomine composition for treating atherosclerosis |
| 06/09/2010 | CN1929818B Pimecrolimus foam composition containing hexylene glycol, optionally oleyl alcohol, dimethylisosorbide and/or medium chain triglycerides |
| 06/09/2010 | CN1926108B Non-nucleotide reverse transcriptase inhibitors |
| 06/09/2010 | CN1914152B New compounds, methods for their preparation and use thereof |
| 06/09/2010 | CN1905876B Use of dipeptidyl peptidase IV inhibitors |
| 06/09/2010 | CN1902159B Novel nitrophenyl mustard and nitrophenylaziridine alcohols and their corresponding phosphates and their use as targeted cytotoxic agents |
| 06/09/2010 | CN1894250B Substituted 8-heteroaryl xanthines |
| 06/09/2010 | CN1893839B Nutritional composition for wound healing |
| 06/09/2010 | CN1886408B Polymorphous forms of rifaximin, processes for production and use in medicinal preparations |
| 06/09/2010 | CN1882589B Novel heterocyclic compounds as HSP90-inhibitors |
| 06/09/2010 | CN1882533B 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
| 06/09/2010 | CN1880319B Tropane derivatives as CCR5 modulators |
| 06/09/2010 | CN1871000B Combinations of potassium channel openers and sodium channel inhibitors or sodium channel-influencing active compounds for treating pain |
| 06/09/2010 | CN1868485B Medicine composition and its application |
| 06/09/2010 | CN1863789B Substituted isoquinolinones |
| 06/09/2010 | CN1852712B Dual NK1/NK3 antagonists for treating schizophrenia |
| 06/09/2010 | CN1834108B Acanthopanax giraldii Harms compound polysaccharide, preparation technique, uses and its compound polysaccharide composition |
| 06/09/2010 | CN1826060B Aiding of cognitive function |
| 06/09/2010 | CN1824064B Use of composition in preparing nutrients with edible and medicinal function for treating pseudomyopia |
| 06/09/2010 | CN1824057B Use of Chinese and western medicine combined composition for preparing product with edible and medicine function for treating nightblindness |
| 06/09/2010 | CN1824052B Use of composition in preparing product for preventing pseudomyopia and true myopia |
| 06/09/2010 | CN1805935B Piperidinium and pyrrolidinium derivatives as ligands for the muscarinic M3 receptor |
| 06/09/2010 | CN1796382B A category of compound of new macrolide, preparation method and application |
| 06/09/2010 | CN1791585B Cyclic sulfonamides for inhibition of gamma-secretase |
| 06/09/2010 | CN1784391B Quinazolines useful as modulators of ion channels |
| 06/09/2010 | CN1780835B Novel fused heterocycles and uses thereof |
| 06/09/2010 | CN1780610B Pharmaceutical composition in the form of a hydrogel for transdermal administration of active substances |
| 06/09/2010 | CN1777430B High drug load mesalazine sachet |
| 06/09/2010 | CN1771239B Vitamin d3 lactone derivatives |
| 06/09/2010 | CN1751051B Cephalosporin in crystalline form |
| 06/09/2010 | CN1735607B 2,4,6-trisubstituted pyrimidines as phosphotidylinositol (PI) 3-kinase inhibitors and their use in the treatment of cancer |
| 06/09/2010 | CN1694874B Benzodiazepine derivatives and pharmaceutical compositions containing them |
| 06/09/2010 | CN1662511B Pharmaceutical salts of reboxetine |
| 06/09/2010 | CN1646115B Use of SARMS in preparing medicine for treating benign prostate hyperplasia |
| 06/09/2010 | CN101730749A Nanoassembled complexes of nucleic acids, avidin and polymers, use and preparation thereof |
| 06/09/2010 | CN101730706A Nmda and mc receptor antagonists exhibiting neuroprotective and memory enhancing activities |
| 06/09/2010 | CN101730705A Process for preparing aromatase inhibitors |
| 06/09/2010 | CN101730704A Stable salts of s-adenosylmethionine and process for the preparation thereof |
| 06/09/2010 | CN101730702A Crystalline forms of topotecan hydrochloride and processes for making the same |
| 06/09/2010 | CN101730701A Hydrated crystalline esters of camptothecin for the treatment of cancer |
| 06/09/2010 | CN101730700A Condensed heterocyclic compounds as inhibitors of protein kinases |
| 06/09/2010 | CN101730699A Fused heterocyclic compounds useful for the treatment of proliferative, allergic, autoimmune or inflammatory diseases |
| 06/09/2010 | CN101730698A Compounds for the treatment of hepatitis c |
| 06/09/2010 | CN101730697A Imidazolopyrimidine analogs and their use as pi3 kinase and mtor inhibitors |
| 06/09/2010 | CN101730696A 3-aza-bicyclo[3.3.0]octane compounds |
| 06/09/2010 | CN101730695A Aminoacyl prodrugs as an active pharmaceutical ingredient for thromboembolic disorders |
| 06/09/2010 | CN101730694A Substituted deuterium enriched thiophenes for the treatment of hypertension |
| 06/09/2010 | CN101730692A Pyridazinone derivatives useful as glucan synthase inhibitors |
| 06/09/2010 | CN101730691A Nitrogenated aromatic 6-membered ring derivative, and pharmaceutical agent comprising the same |
| 06/09/2010 | CN101730690A Sulfonamide compound, and crystal thereof |
| 06/09/2010 | CN101730689A 6 -acyloxy- 7-meth0xy- 2, 2 -dimethylchromane compounds and their use as pigmentation-regulators |
| 06/09/2010 | CN101730685A Novel crystals and process of making 5-({[2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1h-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy- benzoic acid |
| 06/09/2010 | CN101730684A sulfonyl-quinoline derivatives |